Problem statement: Answer the multiple choice question.
Question: Which drug has a 7.287% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) Nc1cc(N)nc(SCC(=O)Nc2ccc(Br)cc2Cl)n1
b.) CC(=O)Nc1ccc(NC(=O)CN(C)CCC#N)cc1
c.) O=C(N1CCOCC1)C(F)(F)C(=O)N1CCOCC1
Answer: a. Nc1cc(N)nc(SCC(=O)Nc2ccc(Br)cc2Cl)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1cc(N)nc(SCC(=O)Nc2ccc(Br)cc2Cl)n1
Nc1cc(N)nc(SCC(=O)Nc2ccc(Br)cc2Cl)n1
N-(4-bromo-2-chlorophenyl)-2-(4,6-diaminopyrimidin-2-yl)sulfanylacetamide